Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

類似資料

• Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
  著者:: Pasternak, Björn, 等
  出版事項: (2019)
• Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
  著者:: Pasternak, Björn, 等
  出版事項: (2020)
• Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study
  著者:: Inghammar, Malin, 等
  出版事項: (2016)
• Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study
  著者:: Svanström, Henrik, 等
  出版事項: (2012)
• Data Mining for Adverse Events of Tumor Necrosis Factor-Alpha Inhibitors in Pediatric Patients: Tree-Based Scan Statistic Analyses of Danish Nationwide Health Data
  著者:: Wintzell, Viktor, 等
  出版事項: (2020)